Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...
Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.
Hosted on MSN1mon
Dr Agarwal’s Healthcare IPO opens tomorrow: GMP, issue details, 10 key things to knowTPG and Temasek-backed Dr Agarwal’s Healthcare IPO opens for subscription on tomorrow (Wednesday, January 29). The company offers a comprehensive range of eye care services, including cataract ...
An anchor lock-in refers to an investor being "locked" into a particular stock or investment due to a psychological or ...
If any of the displayed information needs updating, please click here. For concerns or queries regarding the information, feel free to email us. Medindia Constantly updates the database. However ...
Dr Agarwal's Health Care IPO comprised a fresh issue of up to ₹300 crore alongside an Offer For Sale (OFS) of up to 6.78 crore equity shares valued at ₹2,727.26 crore by promoters and other ...
Commenting on the financial performance, Dr Agarwal's Health Care Ltd CEO Dr Adil Agarwal said, "We have delivered a robust growth of 29.5 per cent in revenue and 26.3 per cent in EBITDA. We have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback